Improving albumin levels among hemodialysis patients: A community-based randomized controlled trial

被引:59
作者
Leon, Janeen B.
Albert, Jeffrey M.
Gilchrist, Gina
Kushner, Irving
Lerner, Edith
Mach, Suzanne
Majerle, Angela
Porter, David
Ricanati, Edmond
Sperry, Laurine
Sullivan, Catherine
Zimmerer, Jennifer
Sehgal, Ashwini R.
机构
[1] Metrohlth Med Ctr, Div Nephrol, Cleveland, OH 44109 USA
[2] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA
[3] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA
[4] Case Western Reserve Univ, Dept Nutr, Cleveland, OH 44106 USA
[5] Case Western Reserve Univ, Dept Biomed Eth, Cleveland, OH 44106 USA
[6] Case Western Reserve Univ, Ctr Reducing Hlth Dispar, Cleveland, OH 44106 USA
[7] Case Western Reserve Univ, Ctr Hlth Care Res & Policy, Cleveland, OH 44106 USA
关键词
hypoalbuminemia; hemodialysis (HD); dietary intake; inflammation;
D O I
10.1053/j.ajkd.2006.03.046
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background Low albumin level is a strong predictor of mortality and morbidity among hemodialysis patients, yet few interventions are available to improve albumin levels. Moreover, the relative importance of nutritional barriers versus inflammation in contributing to hypoalbuminemia is unclear. We sought to determine whether targeting specific nutritional barriers will improve albumin levels. Methods: We conducted a randomized controlled trial involving 180 patients with baseline albumin levels less than 3.7 g/dL (<37 g/L) at 44 long-term hemodialysis facilities. Study coordinators identified and intervened on specific barriers present among intervention patients, whereas control patients continued to receive the usual care. Barriers targeted included poor nutritional knowledge, poor appetite, help needed with shopping or cooking, low fluid intake, inadequate dialysis dose, depression, difficulty chewing, difficulty swallowing, gastrointestinal symptoms, and acidosis. Results: At baseline, intervention and control patients had similar albumin levels, dietary intakes, levels of inflammatory markers, and numbers of nutritional barriers. After 12 months, intervention patients had greater increases in albumin levels compared with control patients (+0.21 versus +0.06 g/dL [+2.1 versus +0.6 g/L]; P < 0.01), as well as greater increases in energy intake (+4.1 versus -0.6 Kcal/d/kg; P < 0.001) and protein intake (+0.13 versus -0.06 g/d/kg; P < 0.001). The intervention appeared most effective for barriers related to poor nutritional knowledge, help needed with shopping or cooking, and difficulty swallowing. About half the subjects had elevated levels of inflammatory markers, but there was no relationship between change in levels of albumin and inflammatory markers. Conclusion: A nutrition intervention tailored to patient-specific barriers resulted in modest improvements in albumin levels regardless of levels of inflammatory markers.
引用
收藏
页码:28 / 36
页数:9
相关论文
共 29 条
[1]  
[Anonymous], AM J KIDNEY DIS, DOI DOI 10.1053/KD.2000.6671
[2]   SERUM-ALBUMIN CONCENTRATION-RELATED HEALTH-CARE FINANCING ADMINISTRATION QUALITY ASSURANCE CRITERION IS METHOD-DEPENDENT - REVISION IS NECESSARY [J].
BLAGG, CR ;
LIEDTKE, RJ ;
BATJER, JD ;
RACOOSIN, B ;
SAWYER, TK ;
WICK, MJ ;
LAWSON, L ;
WILKENS, K .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1993, 21 (02) :138-144
[3]   Therapeutic effects of oral nutritional supplementation during hemodialysis [J].
Caglar, K ;
Fedje, L ;
Dimmitt, R ;
Hakim, RM ;
Shyr, Y ;
Ikizler, TA .
KIDNEY INTERNATIONAL, 2002, 62 (03) :1054-1059
[4]  
CHERTOW GM, 1997, NUTR MANAGEMENT RENA, P257
[5]  
CRAVEN JL, 1988, INT J PSYCHIAT MED, V18, P365
[6]  
*CTR MED MED SERV, 2004, 2004 ANN REP ESRD CL
[7]   WHAT IS SUBJECTIVE GLOBAL ASSESSMENT OF NUTRITIONAL-STATUS [J].
DETSKY, AS ;
MCLAUGHLIN, JR ;
BAKER, JP ;
JOHNSTON, N ;
WHITTAKER, S ;
MENDELSON, RA ;
JEEJEEBHOY, KN .
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 1987, 11 (01) :8-13
[8]   Mechanisms of disease: Acute-phase proteins and other systemic responses to inflammation [J].
Gabay, C ;
Kushner, I .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (06) :448-454
[9]   DEVELOPMENT OF THE KIDNEY-DISEASE QUALITY-OF-LIFE (KDQOL(TM)) INSTRUMENT [J].
HAYS, RD ;
KALLICH, JD ;
MAPES, DL ;
COONS, SJ ;
CARTER, WB .
QUALITY OF LIFE RESEARCH, 1994, 3 (05) :329-338
[10]  
Hulley SB, 1988, DESIGNING CLIN RES